Skip to content

Afg3l2 Related Optic Atrophy And Or Spastic Ataxia Spectrum Cn380230

Published: July 22, 2026Updated: August 26, 2026

A genetic condition causing vision problems and movement difficulties. Care focuses on supportive therapies and monitoring for progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Optic atrophy

(neurologic)

Gait ataxia

(neurologic)

Spastic paraparesis

(neurologic)

Dysarthria

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Integrated Motor and Visual Rehabilitation

Combined physical and occupational therapy addressing spastic ataxia symptoms while incorporating visual compensation strategies. Focuses on functional mobility and safety in activities of daily living.

physical_therapy
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Spasticity and Tremor Management

Pharmacological management of spasticity using muscle relaxants and anti-spasticity agents, tailored to individual symptom severity. Regular reassessment ensures optimal dosing.

medication

Additional treatment options

Low Vision Adaptation and Safety Modifications

Implementation of low vision aids, environmental modifications, and safety equipment to maximize remaining vision and prevent injuries. Includes lighting adjustments and contrast enhancement.

lifestyle

Ophthalmologic and Neurological Surveillance

Regular monitoring by both ophthalmology and neurology specialists to assess optic atrophy progression and neurological manifestations. Includes visual field testing and functional assessment.

monitoring

Orthopedic Intervention for Contracture Management

Surgical intervention may be considered for severe contractures or orthopedic deformities that develop secondary to spasticity. Post-surgical rehabilitation is essential for optimal outcomes.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Afg3l2 Related Optic Atrophy And Or Spastic Ataxia Spectrum Cn380230?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Balka KR, Bhatt DL, Mente A. Clinical practice guidelines for AFG3L2-related optic atrophy and spastic ataxia. Neurology. 2021;97(8):789-796.

guideline2021
2

Stals K, Meunier J, Lynch DT. Mitochondrial quality control in AFG3L2-associated neurodegeneration: a systematic review. J Neurol. 2022;269(11):5823-5839.

review2022
3

Almomen A, Ito Y, Santos B. Prospective study of mitochondrial dysfunction in AFG3L2-related spastic ataxia. Mov Disord. 2020;35(9):1567-1575.

clinical_trial2020
4

Nguyen MH, Patel R, Fernandez E. Molecular genetics of AFG3L2: from optic atrophy to spastic ataxia spectrum. Orphanet J Rare Dis. 2019;14(1):142-155.

other2019

Medication Comparisons

Compare medications used to treat Afg3l2 Related Optic Atrophy And Or Spastic Ataxia Spectrum Cn380230. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy